These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 32366146

  • 1. Gonadotropin-releasing hormone agonist for ovulation trigger - OHSS prevention and use of modified luteal phase support for fresh embryo transfer.
    Castillo JC, Haahr T, Martínez-Moya M, Humaidan P.
    Ups J Med Sci; 2020 May; 125(2):131-137. PubMed ID: 32366146
    [Abstract] [Full Text] [Related]

  • 2. Gonadotropin-releasing hormone agonist (GnRHa) trigger - State of the art.
    Dosouto C, Haahr T, Humaidan P.
    Reprod Biol; 2017 Mar; 17(1):1-8. PubMed ID: 28215488
    [Abstract] [Full Text] [Related]

  • 3. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, Nelson SM.
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intranasal gonadotropin-releasing hormone agonist (GnRHa) for luteal-phase support following GnRHa triggering, a novel approach to avoid ovarian hyperstimulation syndrome in high responders.
    Bar-Hava I, Mizrachi Y, Karfunkel-Doron D, Omer Y, Sheena L, Carmon N, Ben-David G.
    Fertil Steril; 2016 Aug; 106(2):330-3. PubMed ID: 27114332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome.
    Christopoulos G, Vlismas A, Carby A, Lavery S, Trew G.
    Hum Fertil (Camb); 2016 Sep; 19(3):199-206. PubMed ID: 27662416
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger.
    Engmann L, Benadiva C.
    Semin Reprod Med; 2010 Nov; 28(6):506-12. PubMed ID: 21082510
    [Abstract] [Full Text] [Related]

  • 12. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
    Liang IT, Huang HY, Wu HM, Wang HS, Yu HT, Huang SY, Chang CL, Soong YK.
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
    [Abstract] [Full Text] [Related]

  • 13. The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.
    Kol S, Homburg R, Alsbjerg B, Humaidan P.
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):643-7. PubMed ID: 22428986
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF/ICSI for high responders: a randomized controlled trial.
    Santos-Ribeiro S, Mackens S, Popovic-Todorovic B, Racca A, Polyzos NP, Van Landuyt L, Drakopoulos P, de Vos M, Tournaye H, Blockeel C.
    Hum Reprod; 2020 Dec 01; 35(12):2808-2818. PubMed ID: 32964939
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome--a 20-year experience.
    Kol S, Itskovitz-Eldor J.
    Semin Reprod Med; 2010 Nov 01; 28(6):500-5. PubMed ID: 21082509
    [Abstract] [Full Text] [Related]

  • 18. HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes.
    Deepika K, Suvarna R, Sumi M, Snehal D, Arveen V, Anuja K, Gautham P, Kamini R.
    JBRA Assist Reprod; 2021 Feb 02; 25(1):48-58. PubMed ID: 32960521
    [Abstract] [Full Text] [Related]

  • 19. Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases.
    Gurbuz AS, Deveer R, Ozcimen N, Ozcimen EE, Lawrenz B, Banker M, Garcia-Velasco JA, Fatemi HM.
    Gynecol Endocrinol; 2016 Feb 02; 32(1):18-20. PubMed ID: 26487486
    [Abstract] [Full Text] [Related]

  • 20. GnRHa to trigger final oocyte maturation: a time to reconsider.
    Humaidan P, Papanikolaou EG, Tarlatzis BC.
    Hum Reprod; 2009 Oct 02; 24(10):2389-94. PubMed ID: 19608565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.